Matthew Ohr, MD

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses why the future of reasearch in AMD should focus on finding a cure and a "one-and-done" treatment.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses the impact of AMD on patients’ mental health, including higher rates of depression in patients with AMD.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses the potential of Susvimo to change treatment burden in patients with AMD.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses treatments currently available to patients with AMD, including anti-VEGF drugs such as aflibercept and ranibizumab.

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses new treatment options in AMD, including Susvimo (ranibizumab injection, Genentech), Vabysmo (faricimab-svoa, Genentech) and Syfovre (pegcetacoplan, Apellis Pharmaceuticals).

In this video, Matthew Ohr, MD, clinical professor of ophthalmology and visual sciences at The Ohio State University Wexner Medical Center, discusses what physicians can tell patients with dry AMD to help them prevent their condition from worsening, such as quitting smoking and taking AREDS supplements.